Boston, MA, United States of America

Carla Guimaraes

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 32(Granted Patents)


Location History:

  • Cambridge, MA (US) (2023)
  • Boston, MA (US) (2015 - 2024)

Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: **The Innovative Journey of Carla Guimaraes**

Introduction

Carla Guimaraes is a distinguished inventor based in Boston, MA, renowned for her groundbreaking contributions to the field of medicine. With a total of seven patents to her name, her work primarily focuses on the development of advanced therapies for diseases through innovative approaches involving chimeric antigen receptors (CARs).

Latest Patents

Among her latest patents, Guimaraes has developed compositions and methods for treating diseases associated with the expression of CD19 and CD22. These innovations include administering recombinant T cells or natural killer (NK) cells that are engineered with a CD22 CAR and a CD19 CAR. This groundbreaking work not only addresses critical health issues but also provides new avenues for therapeutic interventions.

Furthermore, she has also contributed to the invention of nucleic acid molecules encoding chimeric antigen receptors that comprise a CD20 binding domain. This invention extends the applications of CAR technology to treat diseases linked to CD20 or CD22, showcasing her commitment to advancing medical science through innovative solutions.

Career Highlights

Throughout her career, Carla Guimaraes has collaborated with prestigious organizations, including Novartis AG and the University of Pennsylvania. Her association with these esteemed institutions has allowed her to push the boundaries of research and development in the biotechnological field. With each patent, she solidifies her position as a pioneer in her domain.

Collaborations

In her journey, Guimaraes has worked alongside notable professionals, including her coworkers Jennifer Brogdon and Boris Engels. These collaborations highlight the collaborative spirit of innovation, where sharing ideas and expertise leads to significant advancements in technology and medicine.

Conclusion

Carla Guimaraes exemplifies the essence of innovation in medical science. Her patents indicate a profound dedication to improving therapies for diseases through chimeric antigen receptors. As she continues to pave the way with her inventions, the impact of her work is sure to influence the medical field for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…